FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology. The stage of development of pellucid marginal corneal degeneration (PMCD) is determined based on the refractive indices of the eye, namely, the value of induced corneal astigmatism (IRA) is determined by ophthalmometry, and with IRA<5.0 diopters, stage I of PMCD development is determined. At IRA≥5.0 diopters and ≤10.0 diopters, stage II of PMCD development is determined. When IRA>10.0 diopters determine the III stage of development of PMCD.
EFFECT: method allows to objectively determine the stages of development of PMCD, timely improve treatment and diagnostic measures for patients with PMCD.
1 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CHOOSING A METHOD OF SURGICAL TREATMENT OF STAGE II KERATOCONUS | 2020 |
|
RU2747248C1 |
| METHOD FOR SURGICAL TREATMENT OF SURFACE KERATOLEUKOMA | 1995 |
|
RU2089147C1 |
| METHOD FOR IMPLANTATION OF INTRASTROMAL CORNEAL SEGMENTS IN PELLUCID CORNEAL DEGENERATION | 2017 |
|
RU2663651C1 |
| METHOD OF TREATING PROGRESSIVE KERATOCONUS OF STAGES III-IV | 2024 |
|
RU2822813C1 |
| THERAPY OF CORNEA KERATOCONUS | 2008 |
|
RU2358697C1 |
| METHOD OF TREATING PERIPHERAL CORNEAL ECTASIA (VERSIONS) | 2020 |
|
RU2727042C1 |
| METHOD OF FEMTOLASER REFRACTIVE AUTOKERATOPLASTY IN KERATOCONUS | 2018 |
|
RU2688955C1 |
| METHOD OF FEMTO-LASER REFRACTIVE AUTO-KERATOPLASTY IN KERATOCONUS | 2018 |
|
RU2689758C1 |
| METHOD OF TREATING INITIAL, DEVELOPED AND ADVANCED KERATOCONUS | 2009 |
|
RU2400194C1 |
| METHOD FOR IMPLANTATION OF INTRASTROMAL CORNEAL SEGMENTS IN TYPE I CORNEAL ECTASIA | 2012 |
|
RU2525673C2 |
